Review
An update on the diagnosis and treatment of Parkinson disease
Philippe Rizek, Niraj Kumar and Mandar S. Jog
CMAJ November 01, 2016 188 (16) 1157-1165; DOI: https://doi.org/10.1503/cmaj.151179
Philippe Rizek
Department of Clinical Neurological Sciences, Western University, London, Ont.
MDNiraj Kumar
Department of Clinical Neurological Sciences, Western University, London, Ont.
MD DMMandar S. Jog
Department of Clinical Neurological Sciences, Western University, London, Ont.
MD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Podcast
Article tools
An update on the diagnosis and treatment of Parkinson disease
Philippe Rizek, Niraj Kumar, Mandar S. Jog
CMAJ Nov 2016, 188 (16) 1157-1165; DOI: 10.1503/cmaj.151179
Jump to section
- Article
- What is the pathophysiology of the disease?
- Who gets Parkinson disease?
- How is the diagnosis made?
- How do early- and late-onset disease differ in presentation?
- What tests or investigations are available to help with diagnosis?
- How is Parkinson disease treated?
- What has changed in the treatment of advanced Parkinson disease?
- What is the prognosis?
- Conclusion
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- Unveiling the genes and pathways that are dysregulated in dopaminergic neurons during both familial and sporadic Parkinsons disease
- Efficacy of non-pharmacological interventions on depressive symptoms in patients with Parkinsons disease: a study protocol for a systematic review and network meta-analysis
- Abecedaire de la maladie de Parkinson, partie 1 : le diagnostic
- Parkinson disease primer, part 1: diagnosis
- Using genome-wide association results to identify drug repurposing candidates
- Association of Women-Specific Health Factors in the Severity of Parkinsons Disease
- Health Care Utilization of US Medicare Beneficiaries Living with Parkinsons Disease
- USP30 inhibition induces mitophagy and reduces oxidative stress in parkin-deficient and CCCP-stressed human iPSC-derived neurons
- Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinsons in an international setting
- Protocol for Rhapsody: a longitudinal observational study examining the feasibility of speech phenotyping for remote assessment of neurodegenerative and psychiatric disorders
- Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats
- Non-Genetic Risk Factors for Parkinsons Disease: An Overview of 46 Systematic Reviews
- Genome-wide association, Mendelian Randomization and polygenic risk score studies converge on a role of {beta}-amyloid and APOE locus in Parkinson disease